Real-World Primary Resistance to First-Line Immune-Based Combinations in Patients with Advanced Renal Cell Carcinoma (ARON-1)
- Daniele Santini
- , Haoran Li
- , Giandomenico Roviello
- , Se Hoon Park
- , Enrique Grande
- , Jakub Kucharz
- , Umberto Basso
- , Ondrej Fiala
- , Fernando Sabino Marques Monteiro
- , Alexandr Poprach
- , Sebastiano Buti
- , Javier Molina-Cerrillo
- , Martina Catalano
- , Tomas Buchler
- , Emmanuel Seront
- , Jawaher Ansari
- , Zin W. Myint
- , Marwan Ghosn
- , Fabio Calabrò
- , Ray Manneh Kopp
- Az. Policlinico Umberto I
- University of Kansas Cancer Center
- University of Florence
- University of Texas MD Anderson Cancer Center
- Maria Sklodowska-Curie Institute of Oncology
- IRCCS Istituto Oncologico Veneto - Padova
- Charles University
- Latin American Cooperative Oncology Group-LACOG
- Hospital Sirio-Libanes
- Masaryk Memorial Cancer Institute
- Masaryk University
- University of Parma
- Hospital Ramon y Cajal
- Université catholique de Louvain
- Abu Dhabi Health Services Company
- University of Kentucky
- Hotel Dieu de France University Hospital
- IRCCS Istituti fisioterapici ospitalieri - Istituto Regina Elena
- Clinical Oncology
- Army Hospital Research and Referral
- Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
- University of Rome La Sapienza
- University Hospital S. Orsola
- University of Bologna
- Hospital Israelita Albert Einstein
- Macerata Hospital
- General Director AST3
- National Cancer Centre
- Attikon University Hospital
- University of Bari
Research output: Contribution to journal › Article › peer-review
6
Link opens in a new tab
Scopus
citations